Skip to main content

Table 2 Characteristics of participants with HAART over one year grouped by total GDS severity

From: Neuropsychological outcomes in adults commencing highly active anti-retroviral treatment in South Africa: a prospective study

  

GDS Groups

  
 

1

2

3

p-value

Number Women (%)

21 (80.7)

21 (84)

21 (67.7)

0.34

Number isiXhosa (%)

22 (88.5)

23 (95.7)

30 (96.8)

0.22

Age median (IQR)

30 (27-31)

28 (25-32)

30 (28-32)

0.34

Education median (IQR)

12 (10-12)

10 (10-12)

9 (8-10)

0.00*

CD4 One median (IQR)

180 (146-199)

182.5 (143-221)

138 (100-205)

0.32

CD4_Two median (IQR)

395 (271-465)

340 (263-518)

302 (156-388)

0.07

Duration of HAART in months median (IQR)

11 (10-12)

11 (10-14)

10 (8-12)

0.45

CPE median (IQR)

2 (1.5-2.5)

2 (1.5-2.25)

2 (1.5-2.5)

0.98

GDS Change median (IQR)

0 (-0.67-0.67)

0.13 (-0.67-0.27)

0.6 (0.2-0.8)

0.00*